TY - JOUR
T1 - Interferons
T2 - Laboratory to clinic investigations
AU - Platanias, L. C.
PY - 1995/1/1
Y1 - 1995/1/1
N2 - Interferons are pleiotropic cytokines that exhibit multiple biological effects on cells and tissues, including antiproliferative, antiviral, and immunomodulatory activities. Despite the well-documented activity of interferons in the treatment of certain malignancies, the precise mechanisms by which these cytokines inhibit malignant cell growth remain unknown. Recently, several laboratory studies have provided important dues on the cellular events elicited during the binding of interferons to their receptors on malignant cells. The continuation and expansion of such studies should help us understand the mechanisms by which interferons elicit their antitumor effects and provide a basis for the development of new strategies in their clinical use.
AB - Interferons are pleiotropic cytokines that exhibit multiple biological effects on cells and tissues, including antiproliferative, antiviral, and immunomodulatory activities. Despite the well-documented activity of interferons in the treatment of certain malignancies, the precise mechanisms by which these cytokines inhibit malignant cell growth remain unknown. Recently, several laboratory studies have provided important dues on the cellular events elicited during the binding of interferons to their receptors on malignant cells. The continuation and expansion of such studies should help us understand the mechanisms by which interferons elicit their antitumor effects and provide a basis for the development of new strategies in their clinical use.
UR - http://www.scopus.com/inward/record.url?scp=0028791799&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028791799&partnerID=8YFLogxK
U2 - 10.1097/00001622-199511000-00015
DO - 10.1097/00001622-199511000-00015
M3 - Review article
C2 - 8547406
AN - SCOPUS:0028791799
SN - 1040-8746
VL - 7
SP - 560
EP - 565
JO - Current Opinion in Oncology
JF - Current Opinion in Oncology
IS - 6
ER -